Related Experiment Video
Updated: Sep 14, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Antimicrobial peptides with high bioactivity against MDR isolates: Addressing public health concerns
Ali Salehi1, Anat Yanai2, Amelia Richter2
1Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Canada; Public Health Laboratory, British Columbia Centre for Disease Control, Canada; Department of Medical Genetics, University of British Columbia, Canada.
Abstract:
Antimicrobial resistance is a rapidly escalating global health concern, largely driven by the overuse and misuse of antibiotics in agriculture and clinical settings. There is an urgent and currently unmet need for effective therapeutics against multi-drug resistant (MDR) pathogens. Antimicrobial peptides (AMPs) are a diverse class of cationic peptides that have the potential to overcome extant resistance mechanisms. We evaluated the antimicrobial efficacy of 13 structurally distinct antimicrobial peptides against a panel of drug-resistant Escherichia coli strains. Toxicity assays, including hemolysis and cell viability tests, were performed to determine therapeutic indices and assess the clinical potential of those select peptides. Our findings indicate that, relative to susceptible reference strains, the tested AMPs retain robust bioactivity against known MDR isolates, exhibiting only marginal or no decrease in antimicrobial efficacy. Among them, TeRu4 emerged as the lead candidate, with a minimum inhibitory concentration of 0.5 μg/mL and a therapeutic index exceeding 256. This study underscores the potential of AMPs to act as powerful alternatives to traditional antibiotics, offering new possibilities to address public health concerns surrounding drug-resistant bacterial infections.
Insights
Antimicrobial peptides show strong activity against drug-resistant bacteria, offering a promising alternative to traditional antibiotics. TeRu4 is a potential lead candidate for treating infections caused by multi-drug resistant pathogens.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Antimicrobial resistance (AMR) is a critical global health threat.
- Overuse of antibiotics in agriculture and medicine drives AMR.
- There is an urgent need for novel therapeutics against multi-drug resistant (MDR) pathogens.
Purpose of the Study:
- To evaluate the antimicrobial efficacy of structurally distinct antimicrobial peptides (AMPs) against drug-resistant Escherichia coli.
- To assess the toxicity and therapeutic potential of selected AMPs.
- To identify lead candidate AMPs for combating MDR bacterial infections.
Main Methods:
- Screening of 13 diverse antimicrobial peptides against MDR E. coli strains.
- Determination of minimum inhibitory concentrations (MICs).
- Toxicity assays including hemolysis and cell viability tests to calculate therapeutic indices.
Main Results:
- AMPs maintained robust bioactivity against MDR E. coli isolates, with minimal loss of efficacy compared to susceptible strains.
- TeRu4 demonstrated potent antimicrobial activity with an MIC of 0.5 μg/mL.
- TeRu4 exhibited a high therapeutic index, exceeding 256, indicating favorable safety and efficacy.
Conclusions:
- Antimicrobial peptides show significant potential as alternatives to conventional antibiotics.
- AMPs can effectively combat drug-resistant bacterial infections.
- TeRu4 is a promising candidate for further development as a therapeutic agent against MDR pathogens.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Biological Methods for Microbial Control

